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Abstract Calsequestrin (CSQ) is a high capacity Ca2+ binding
protein in the junctional sarcoplasmic reticulum of striated
muscles, and has been shown to regulate the ryanodine receptor
(RyR) through triadin and junctin. In order to identify the
functional roles of specific regions on CSQ, several CSQ
deletion mutants were prepared by molecular cloning and
Escherichia coli expression. 45Ca2+ overlay assay using a native
gel system revealed that the major Ca2+ binding motif of CSQ
resides in the asp-rich region (amino acids 354^367). In an in
vitro binding assay using a glutathione-S-transferase affinity
column, the interaction between CSQ and triadin was found to be
Ca2+-dependent, and the site of interaction was confined to the
asp-rich region of CSQ. Our results suggest that the asp-rich
region of CSQ could participate in the RyR-mediated Ca2+
release process by offering a direct binding site to luminal Ca2+
as well as triadin. ß 2000 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
The sarcoplasmic reticulum (SR) represents the major stor-
age site for intracellular Ca2, essential for contraction of
striated muscle cells. The ryanodine receptor (RyR) located
in the terminal cisternae of SR membrane constitutes the
channel for rapid Ca2 release in response to depolarization
of the surface membrane [1]. It is believed that in skeletal
muscles, the dihydropyridine receptor (DHPR) located in
the transverse tubules senses the arrival of an action potential
and directs opening of the Ca2 release channel through a
direct interaction with RyR [2^4]. The activities of RyRs are
known to be modulated by proteins such as FK-506 binding
protein and calsequestrin (CSQ) [5^7]. CSQ is localized in the
lumen of SR and binds Ca2 with high capacity and moderate
a⁄nity [8]. It is a highly hydrophilic protein, containing clus-
ters of positively and negatively charged residues dispersed
throughout its sequence with a particular region enriched in
aspartate (asp) residues at its carboxyl-terminus [9]. Triadin
and junctin are structurally similar integral membrane pro-
teins having a short amino-terminal cytoplasmic domain and
a long stretch exposed to the luminal side of the SR [10,11].
The luminal region is especially enriched in multiple clusters
of alternating lysine and glutamic acid residues, named as the
KEKE motif [11^13]. Recent reports suggest that triadin can
inhibit the activity of RyR in skeletal muscle by decreasing
open probability of the Ca2 release channel [14,15]. CSQ
may also be involved in the regulation of RyR indirectly
through its interaction with triadin and junctin [16,17]. How-
ever, the binding regions for triadin and junctin in CSQ have
not been identi¢ed. The interaction between CSQ and triadin
(and junctin) inside the SR lumen may be due to the partic-
ular charged domains in these proteins. In this study, we
prepared various CSQ deletion mutants to identify the regions
for binding of Ca2 and triadin. We found that the asp-rich
region of CSQ not only binds to triadin, but also binds to
Ca2. This dual function of the asp-rich region is likely to be
responsible for the Ca2-dependent interaction between tria-
din and CSQ.
2. Materials and methods
2.1. Materials
Glutathione^Sepharose 4B column and anti-glutathione S-transfer-
ase (GST) antibody were purchased from Amersham Pharmacia (Pis-
cataway, NJ, USA). The restriction enzymes were purchased from
New England BioLabs (Beverly, MA, USA). 45CaCl2 (speci¢c activ-
ity, 10 mCi/mmol) was obtained from NEN (Boston, MA, USA).
Protease inhibitors and anti-triadin antibody were purchased from
Boehringer Mannheim (Indianapolis, IN, USA) and A⁄nity Bio Re-
agents (Golden, CO, USA), respectively.
2.2. Generation and puri¢cation of GST^CSQ fusion proteins
To examine the role of the putative junctional domain (86^191
residues) [18] and the asp-rich region (354^367 residues) at C-terminus
of CSQ, several deletion mutants of CSQ were produced as GST
fusion proteins (see Fig. 1A). cDNA fragments ampli¢ed by polymer-
ase chain reaction (PCR) were subcloned into pGEX-4T-1 vectors and
con¢rmed by DNA sequencing. The GST fusion proteins were ex-
pressed in Escherichia coli BL21 (DE3) cells by addition of 0.1 mM
isopropyl L-D thiogalactopyranoside (IPTG) and the bacterial cell
lysates were prepared by sonication. After centrifugation at 15 000
rpm, the supernatants were incubated with a glutathione^Sepharose
4B a⁄nity column for 2 h at 4‡C. After washing several times with
phosphate-bu¡ered saline, the bound proteins were eluted by reduced
glutathione elution bu¡er according to the manufacturer’s protocol
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(Amersham Pharmacia). The puri¢ed proteins were examined by Coo-
massie blue staining.
2.3. Western blot and 45Ca2+ overlay assay
SDS^PAGE was performed with the bu¡er system of Laemmli et
al. [19] with an 8 or 12% polyacrylamide gel. The separated proteins
were electrophoretically transferred onto nitrocellulose membrane.
Immunoblotting was conducted using either anti-GST, anti-CSQ,
anti-triadin or anti-junctin antibody. 45Ca2 overlay assay was per-
formed as described previously [20]. The membrane was incubated
with the overlay bu¡er containing 60 mM KCl, 5 mM MgCl2 and
10 mM imidazole, pH 6.8 for 10 min at room temperature. The over-
lay was performed using 0.1 mCi of 45Ca2/blot. Unbound 45Ca2
was removed by washing with 50% ethanol solution, and bound ra-
dioactivity was visualized by exposure to X-ray ¢lm.
A 6% native gel electrophoresis was also performed as described
previously [21]. The gels were transferred onto nitrocellulose mem-
brane for immunoblotting and 45Ca2 overlay assay.
2.4. Preparation of SR vesicles from rabbit skeletal muscle
A heavy fraction of SR was prepared from rabbit back and leg fast
twitch muscle as described previously [22]. The ¢nal pellets were sus-
pended in a solution containing 0.15 M KCl, 20 mM MOPS (pH 6.8)
and 0.3 M sucrose in the presence of protease inhibitors (1 WM pep-
statin, 1 WM leupeptin, 100 WM phenylmethylsulfonyl £uoride
(PMSF) and 1 WM trypsin inhibitor). The protein concentrations
were determined by the Bradford method using bovine serum albumin
as the standard. The SR vesicles were quickly frozen in liquid nitrogen
and stored at 370‡C until use.
2.5. In vitro binding assay using glutathione^Sepharose 4B column
In vitro binding assay was performed as described previously [17].
An a⁄nity column was prepared by immobilizing 100^150 Wg of
GST^CSQ fusion proteins on 50 Wl of glutathione^Sepharose beads
for 2 h at 4‡C (Pharmacia). The SR vesicles from rabbit skeletal
muscles (10 mg/ml) were solubilized in a lysis bu¡er containing 2%
Triton X-100, 20 mM Tris^HCl, pH 7.4, 1 mM dithiothreitol (DTT),
1 M NaCl and protease inhibitors (1 WM pepstatin, 1 WM leupeptin,
100 WM PMSF, and 1 WM trypsin inhibitor). The solubilized mem-
branes were centrifuged at 65 000 rpm in a Beckman ultracentrifuge
using the TLA-100.3 rotor for 45 min. The supernatant was collected
and diluted 1:10 with the dilution bu¡er containing 20 mM Tris^HCl,
pH 7.4, 1 mM DTT and protease inhibitors (1 WM pepstatin, 1 WM
leupeptin, 100 WM PMSF, and 1 WM trypsin inhibitor), and incubated
for 4 h with the puri¢ed GST^CSQ fusion protein^Sepharose 4B.
After the incubation, the fusion protein^Sepharose complexes were
washed with the bu¡er containing 0.2% Triton X-100, 20 mM Tris^
HCl, pH 7.4, and 0.15 M NaCl. The bound proteins were eluted by
boiling in the SDS sample bu¡er [19] or eluted by 20 mM CaCl2 in the
washing bu¡er. The eluates were subjected to immunoblotting with
anti-triadin or anti-junctin antibody.
3. Results
3.1. Preparation of GST-CSQ deletion mutants
CSQ contains a putative junctional domain (amino acids
(aa) 86^191) [18] and an asp-rich region at the carboxyl-ter-
minus (aa 354^367). To investigate the function of these do-
mains, ¢ve deletion mutants of CSQ were generated by using
PCR from rabbit skeletal CSQ cDNA: N-CSQ (aa 1^86), C-
CSQ (aa 193^367), vjunc-CSQ (lacking aa 86^191), vasp-CSQ
(lacking aa 354^367) and vjunc-vasp-CSQ (Fig. 1A). For gen-
eration of the vjunc-CSQ construct, the amino-terminus of
CSQ (N-CSQ, 1^258 bp) and carboxyl-terminus of CSQ (C-
CSQ, 579^1101 bp) were ampli¢ed by PCR, and ligated to-
gether in a bacterial expression vector, pGEX-4T-1. For con-
venience of protein puri¢cation, these CSQ mutants were ex-
pressed in E. coli (BL21-DE3) as GST fusion proteins.
Following an induction with 0.1 mM IPTG for 6 h, the var-
ious GST^CSQ fusion proteins were puri¢ed using a gluta-
thione^Sepharose 4B column. Large amounts of the fusion
proteins were eluted from the column as detected with Coo-
massie blue staining (Fig. 1B).
To con¢rm the expression of GST^CSQ mutant proteins,
Western blot assays were performed. The GST^CSQ fusion
proteins with the expected molecular weights were recognized
by the anti-GST antibody (Fig. 2A). The identities of the CSQ
mutants were also con¢rmed by Western blot with polyclonal
antibody raised against CSQ (data not shown).
3.2. The asp-rich region of CSQ is a Ca2+ binding domain
To identify the putative Ca2 binding motifs in CSQ,
45Ca2 overlay assay was performed with the puri¢ed GST^
CSQ deletion mutants. As shown in Fig. 2B, the vasp-CSQ
mutant could bind to 45Ca2 (lane 5), when the protein was
run in a SDS-denaturing gel for blotting. Similar 45Ca2 bind-
ing was observed with wild type (wt)-CSQ (lane 3), vjunc-
CSQ (lane 4) and vjunc-vasp-CSQ (lane 6). The X-ray crystal
structure of the full-length CSQ revealed that most of the
negatively charged residues are located inside the protein,
Fig. 1. Preparation of wild type and deletion mutated CSQ using glutathione^Sepharose 4B a⁄nity column. A: A schematic diagram illustrat-
ing the di¡erent domains of CSQ, and the prepared various deletion mutants used for the present study. B: Puri¢ed GST-fusion wt-CSQ and
various mutant CSQ expressed in E. coli (BL21(DE3)) were separated in an 8% SDS^PAGE gel. The arrows indicate the positions of each
GST fusion proteins. Lane 1, protein size marker; lane 2, cell supernatant including GST^wt-CSQ; lane 3, GST^wt-CSQ; lane 4, cell superna-
tant including GST^vjunc-CSQ; lane 5, GST^vjunc-CSQ; lane 6, cell supernatant including GST^vasp-CSQ; lane 7, GST^vasp-CSQ; lane 8,
cell supernatant including GST^vjunc-vasp-CSQ; lane 9, GST^vjunc-vasp-CSQ.
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which may participate in intra- and intermolecular oligomeri-
zation of CSQ [23]. Since the 45Ca2 overlay assay shown in
Fig. 2B was performed with a denaturing gel containing SDS,
it was possible that these negatively charged internal residues
were exposed to 45Ca2 and caused the binding shown in Fig.
2B.
To test Ca2 binding to the CSQ mutants in native con-
formation, the puri¢ed CSQ mutants were subjected to a na-
tive gel electrophoresis. For quantitative purpose, an equal
amount of protein was loaded to the gel, as revealed by West-
ern blot (Fig. 2C). A 45Ca2 overlay assay using the blot from
the native gel revealed little or no binding of 45Ca2 to the
vasp-CSQ and vjunc-vasp-CSQ proteins which lack the asp
motif of CSQ (Fig. 2D, lanes 3 and 4). In contrast, the 45Ca2
binding property was retained in the vjunc-CSQ mutant (Fig.
2D, lane 2), similar to wt-CSQ (Fig. 2D, lane 1). This result
suggests that the asp-rich region at the C-terminus is a major
Ca2 binding motif on CSQ.
3.3. The asp-rich region of CSQ interacts with triadin or
junctin
To investigate the nature of interaction between CSQ and
triadin, an in vitro binding assay was performed in the pres-
ence of various [Ca2] (0^2 mM). The junctional SR vesicles
Fig. 2. Identi¢cation of Ca2 binding domains in CSQ using 45Ca2 overlay assay under denaturing and native conditions. Puri¢ed GST^CSQ
mutants (10 Wg) were subjected to 8% SDS (A, B) or 6% native PAGE (20) (C, D). The immunoblotting was carried out with anti-GST anti-
body (A) or anti-CSQ antibody (C). Autoradiographs of the gels after overlaying with 45Ca2 (B, D). Lane 1, control cell lysates; lane 2,
GST; lane 3, GST^wt-CSQ; lane 4, GST^vjunc-CSQ; lane 5, GST^vasp-CSQ; lane 6, GST^vjunc-vasp-CSQ (A, B). Lane 1, GST^wt-CSQ;
lane 2, GST^vjunc-CSQ; lane 3, GST^vasp-CSQ; lane 4, GST^vjunc-vasp-CSQ (C, D).
Fig. 3. Ca2-dependency of triadin^CSQ interaction (A), and an identi¢cation of triadin binding domain on CSQ (B). In vitro binding assay of
triadin was performed with puri¢ed wt-CSQ associated GST a⁄nity column (A). The puri¢ed wt-CSQ a⁄nity beads were incubated with Tri-
ton X-100 solubilized rabbit skeletal heavy SR (500 Wg) in various Ca2 concentrations. Lane 1, SR; lane 2, control a⁄nity beads without sam-
ple; lane 3, GST a⁄nity beads without sample; lane 4, 1 mM EGTA; 5, 0.1 mM Ca2 ; lane 6, 0.5 mM Ca2 ; lane 7, 1.0 mM Ca2 ; lane 8,
2.0 mM Ca2. After washing several times, the bound proteins were eluted by SDS-sample bu¡er, and were subjected to 8% SDS^PAGE, and
immunoblotting was done with anti-triadin antibody. (B) The same in vitro binding assay of triadin was performed with several CSQ deletion
mutants in the absence of Ca2. Lane 1, SR; lane 2, control a⁄nity beads; lane 3, GST a⁄nity beads; lane 4, wt-CSQ a⁄nity column; lane 5,
vjunc-CSQ a⁄nity beads; lane 6, vasp-CSQ a⁄nity beads; lane 7, vjunc-vasp-CSQ a⁄nity beads; lane 8, N-CSQ a⁄nity beads; lane 9,
C-CSQ a⁄nity beads.
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from rabbit skeletal muscle were solubilized with 2% Triton
X-100, and applied to GST^wt-CSQ bound glutathione^Se-
pharose 4B beads. Proteins that interact with GST^wt-CSQ
were separated on an 8% SDS^PAGE after boiling the protein
complexes in the SDS loading bu¡er. These proteins were
probed with an anti-skeletal triadin antibody in a Western
blot assay (Fig. 3). As shown in Fig. 3A, increasing the con-
centration of Ca2 in the incubation medium resulted in a
progressive loss of interaction between triadin and CSQ, sug-
gesting that the interaction is Ca2 concentration-dependent.
A similar result was reported earlier by a co-immunoprecipi-
tation assay [17].
To search for the domains of CSQ that could serve for the
interaction with triadin, in vitro binding assays with the var-
ious CSQ mutants were conducted in the presence of 1 mM
ethylene glycol bis (L-aminoethylether)-N,NP tetraacetic acid
(EGTA) to enhance the interaction between CSQ and triadin
(Fig. 3B). The carboxyl terminal portion of CSQ (C-CSQ)
interacted with triadin (lane 9), whereas the amino-terminus
of CSQ (N-CSQ) did not bind to triadin (lane 8). CSQ lacking
the putative junctional domain (vjunc-CSQ) also exhibited
signi¢cant binding to triadin (lane 5). The interaction between
CSQ and triadin was completely abolished in the CSQ mu-
tants lacking the asp-rich region (lanes 6 and 7).
The interaction between C-CSQ and triadin also exhibited a
strong Ca2 dependence, in such a way that increasing Ca2
concentration (from 0 to 5 mM) resulted in a gradual disso-
ciation between triadin and C-CSQ (Fig. 4A). In light of the
evidence that junctin plays a similar role to triadin in striated
muscles [13,17], we also examined the possible interaction be-
tween junctin and C-CSQ. It was found that junctin also
showed a Ca2-dependent interaction with C-CSQ (Fig. 4B).
These results suggest that the asp-rich region of CSQ could be
the binding site for Ca2 as well as triadin and junctin.
4. Discussion
CSQ, a major Ca2 binding protein located in the junction-
al SR lumen in striated muscles [24,25] undergoes a conforma-
tional change upon Ca2 binding [29] and has an intrinsic
property of oligomerization [30]. There is growing evidence
that CSQ may actively participate in regulating the amounts
of Ca2 release through the RyR/Ca2 release channel [6,26^
28]. The regulatory e¡ect of CSQ may be mediated by the
CSQ-anchoring proteins such as triadin and junctin [16,17].
Triadin and junctin are single transmembrane proteins with a
short amino-terminal segment located in the cytoplasm, and a
large charged carboxyl-terminal segment in the luminal side of
SR [10,11]. These anchoring proteins could be implicated in
the intermolecular interactions between CSQ and the RyR
[16,17].
In the present study, we found that the interaction between
CSQ and triadin was abolished when the asp-rich region was
deleted from CSQ, suggesting that the asp-rich region is the
interaction site for CSQ and triadin. This result is in disagree-
ment with the proposal by Wang et al. [23] who argued that
the amino-terminal arm of CSQ is responsible for its local-
ization to RyR through interactions with triadin and junctin.
A recent report by Kobayashi et al. [13] showed that a
speci¢c KEKE motif (200^224) in the luminal side of cardiac
triadin is responsible for interaction with CSQ. Amino acid
sequences (aa 1^257) containing the speci¢c KEKE motif are
predicted to be identical in all triadin isoforms [31]. Thus,
regardless of di¡erent isoforms, it is possible that an asp-
rich region of CSQ interacts with the KEKE motif of triadin
electrostatically, and therefore stabilizes the binding between
CSQ and triadin.
A recent study by Nori et al. [32] showed that a CSQ mu-
tant lacking the asp-rich region segregated to terminal cister-
nae of skeletal muscles as shown by immuno£uorescence tech-
nique, suggesting that in vivo targeting of CSQ to terminal
cisternae may depend on unknown or more complex mecha-
nism.
Using a 45Ca2 overlay assay, we found that the Ca2 bind-
ing capability of CSQ in the native condition was almost
completely eliminated when the asp-rich motif was deleted
from the protein (Fig. 2D), although all CSQ mutants could
bind to Ca2 in the denaturing condition. This result indicates
that the speci¢c Ca2 binding capacity of CSQ is highly de-
pendent on the proper conformation of the protein, and the
asp-rich region of CSQ could serve as the major Ca2 binding
motif. Therefore, it is likely that triadin and Ca2 may share
the common binding domain that is the asp-rich region.
We also showed that the interaction between CSQ and tri-
adin exhibits a strong Ca2-dependency. This is in agreement
with the previous report by Zhang et al. [17], who demon-
strated that the association between triadin (junctin) and CSQ
Fig. 4. In vitro binding of triadin (A) and junctin (B) with C-termi-
nus CSQ in various Ca2 concentrations. In vitro binding of triadin
(A) or junctin (B) was performed with puri¢ed GST-C-terminus
(C-CSQ) associated GST a⁄nity beads. The puri¢ed C-CSQ a⁄nity
beads were incubated with Triton X-100 solubilized rabbit skeletal
heavy SR (500 Wg) in various Ca2 concentrations. After washing
several times, the bound proteins were eluted by 20 mM CaCl2 bu¡-
er containing 0.2% Triton X-100, 150 mM NaCl, and 20 mM Tris^
HCl (pH 7.4), and subjected to 12% SDS^PAGE, and immunoblot-
ting was done with anti-triadin antibody or anti-junctin antibody.
As a control, C-CSQ in each sample was eluted by SDS sample
bu¡er, and then immunoblotting was done by anti-CSQ antibody
(C). Lane 1, SR; lane 2, control a⁄nity beads; lane 3, GST a⁄nity
beads; lane 4, 1 mM EGTA; lane 5, 0.5 mM Ca2 ; lane 6, 1.0 mM
Ca2 ; lane 7, 2.0 mM Ca2 ; lane 8, 5.0 mM Ca2.
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was strongest in the absence of Ca2. Here, using an in vitro
binding assay with C-CSQ mutant (aa 192^367) containing
asp-rich region, we showed that the association between tri-
adin (junctin) and C-CSQ still had a strong dependence on
Ca2, such that millimolar concentrations of Ca2 can disso-
ciate the interaction between CSQ and triadin (junctin). These
results would explain the apparent Ca2-dependent interac-
tion between triadin (junctin) and CSQ. It is possible that
the elevated Ca2 could bind to the asp-rich motif on CSQ,
and cause a conformational change in CSQ allowing dissoci-
ation of triadin or junctin from CSQ. Alternatively, Ca2
could directly compete with triadin molecules for the same
binding site.
Our results add new insights to the intermolecular interac-
tions among the junctional proteins present in the SR mem-
brane and also the functional roles of CSQ and triadin (junc-
tin) in the Ca2 release process during the excitation^
contraction coupling in striated muscles. When muscle is at
the resting state, the majority of CSQ will be occupied with
luminal Ca2 forming oligomer or polymer [23,29,30] ; triadin
is free to interact with RyR which could have an inhibitory
role on the Ca2 release channel activity [14,15]. In response
to an excitation signal from DHPR in the transverse tubule,
opening of the RyR/Ca2 release channels causes a transient
decrease in the luminal Ca2 concentration. This decrease in
Ca2 may lead to an association of CSQ with triadin and,
therefore, dissociation of triadin from RyR. The RyR pro-
teins, once free from binding to triadin (and therefore the
removal of the partial inhibitory action of triadin), will enter
a state with elevated Ca2 release activity. In principle, this
could serve as a positive feedback mechanism allowing for
further release of Ca2 into the myoplasm.
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